Vitamin C is a powerhouse nutrient essential for overall health, particularly for maintaining vibrant, youthful skin. It acts ...

People with type 2 diabetes taking the highest dose of Eli Lilly’s experimental drug orfoglipron lowered their blood sugar and lost 16 pounds on average after 40 weeks.

A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...

Weight loss drugs, already a relatively new and revolutionary concept within the medical industry, are shaking things up once again. Move over Ozempic, pharmaceutical giant Eli Lilly […] ...

Pharmaceutical giant Eli Lilly (LLY) surged 14% last week to $840 per share following positive Phase 3 trial results for its ...

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...

Eli Lilly announced plans to manufacture its new weight loss pill, orforglipron, in the U.S., with global distribution set to begin in 2026, Bloomberg reported April 18. The move comes as President ...

Drug manufacturer Eli Lilly has announced their new daily pill may be as effective in lowering blood sugar and aiding weight ...

Doctors and patients have been hoping for a pill version that would be easier to take, in contrast to an injectable.

Meanwhile, Stat reports that in Ireland — a global pharmaceutical hub — potential U.S. tariffs are raising concerns. Also in the news: Novo Nordisk, PBM legislation in statehouses, same-day ...

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...